ENO1 and neoplasm: ENO1, as a key glycolytic enzyme involved in catalysing the conversion of 2‐phospho‐D‐glycerate to phosphoenolpyruvate, can enhance glycolytic process in tumour cells because of the Warburg effect.25, 26